 Sanjay Maraboyina
| Title | Associate Professor |
|---|
| Institution | University of Arkansas for Medical Sciences |
|---|
| Department | Radiation Oncology, College of Medicine |
|---|
| Division | Radiation Oncology Faculty |
|---|
| Address | 4104 Outpatient Circle
Mail Slot # 771
Little Rock AR 72205
|
|---|
| Phone | 501-603-8860 |
|---|
| vCard | Download vCard |
|---|
|
|
|
 Overview Dr. Sanjay Maraboyina is an Assistant Professor in the Radiation Oncology Department at the UAMS College of Medicine, and is board certified by the American Board of Radiology. He received his medical degree from Drexel University College of Medicine. Dr. Maraboyina went on to complete an internship in internal medicine at Christ Hospital in Cincinnati, Ohio and a Radiation Oncology residency at the University of Kansas Medical Center. He also completed a Prostate Brachytherapy Scholarship at the MD Anderson Cancer Center in Houston.Dr. Maraboyina has done research work on a number of topics, including the effects of brachytherapy for prostate cancer and the effects of insulin and glucocorticoids on the cell cycle. His publications include abstracts in the International Journal of Radiation Oncology, the official journal of the American Society for Radiation Oncology (ASTRO), as well as presenting an abstact at the American Society of Hematology Annual Meeting.
Research NRG-GU009 (MARABOYINA, SANJAY)Sep 15, 2021 - Sep 14, 2031 NRG Oncology Foundation
Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk with Radiation (PREDICT-RT*) (273360)
Role: Principal Investigator |
| PROTOCOL NRG-LU005 (MARABOYINA, SANJAY)Nov 15, 2019 NIH/Nat. Cancer Institute - Pass Through: NRG Oncology Foundation
NRG-LU005, Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase II/III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab (260043)
Role: Principal Investigator |
| PROTOCOLNRG-LU005 (MARABOYINA, SANJAY)Nov 15, 2019 NIH/Nat. Cancer Institute - Pass Through: NRG Oncology Foundation
No FP attached
Role: Principal Investigator |
| NRG - GU005 (MARABOYINA, SANJAY)Apr 20, 2018 NIH/Nat. Cancer Institute - Pass Through: NRG Oncology Foundation
No FP attached
Role: Principal Investigator |
| NRG-GU005 (MARABOYINA, SANJAY)Apr 20, 2018 NIH/Nat. Cancer Institute - Pass Through: NRG Oncology Foundation
NRG-GU005: Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Role: Principal Investigator |
Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Faculty can login to make corrections and additions.
Don't see publications published under other names? Login to add alternative names.
-
Tu SM, Chen JZ, Singh SR, Maraboyina S, Gokden N, Hsu PC, Langford T. Stem Cell Theory of Cancer: Clinical Implications for Cellular Metabolism and Anti-Cancer Metabolomics. Cancers (Basel). 2024 Jan 31; 16(3). PMID: 38339375.
-
Tu SM, Aydin AM, Maraboyina S, Chen Z, Singh S, Gokden N, Langford T. Stem Cell Origin of Cancer: Clinical Implications for Cancer Immunity and Immunotherapy. Cancers (Basel). 2023 Nov 13; 15(22). PMID: 38001645.
-
Nissen C, Ying J, Kalantari F, Patel M, Prabhu AV, Kesaria A, Kim T, Maraboyina S, Harrell L, Xia F, Lewis GD. A Prospective Study Measuring Resident and Faculty Contour Concordance: A Potential Tool for Quantitative Assessment of Residents' Performance in Contouring and Target Delineation in Radiation Oncology Residency. J Am Coll Radiol. 2024 Mar; 21(3):464-472. PMID: 37844655.
-
Boria AJ, Narayanasamy G, Bimali M, Maraboyina S, Kalantari F, Sabouri P, Su Z. Cleaning the dose falloff with low modulation in SBRT lung plans. Biomed Phys Eng Express. 2023 05 04; 9(4). PMID: 37140156.
-
Tu SM, Aydin AM, Maraboyina S, Chen Z, Singh S, Gokden N, Langford T. Stem Cell Origin of Cancer: Implications of Oncogenesis Recapitulating Embryogenesis in Cancer Care. Cancers (Basel). 2023 Apr 27; 15(9). PMID: 37173982.
-
Hallgren E, Ayers BL, Moore R, Purvis RS, McElfish PA, Maraboyina S, Bryant-Smith G. Facilitators and barriers to employment for rural women cancer survivors. J Cancer Surviv. 2023 10; 17(5):1338-1346. PMID: 35142993.
-
Patel MA, Fazli Y, Sivakumar S, Dennis C, Maraboyina S, Prabhu AV, Kim T. Brachytherapy vs external beam therapy among NSCLC patients undergoing limited surgical resection. J Cancer Res Clin Oncol. 2021 Mar; 147(3):853-861. PMID: 32940781.
-
Patel M, Bimali M, Howie C, McClain P, Mehta S, Harari M, Hans HS, Agarwal A, Pederson A, Maraboyina S, Kim T. The Role of Radiotherapy Among Patients With Prostate Ductal Adenocarcinoma. Clin Genitourin Cancer. 2021 02; 19(1):e41-e50. PMID: 33616071.
-
Patel M, Nowsheen S, Maraboyina S, Xia F. The role of poly(ADP-ribose) polymerase inhibitors in the treatment of cancer and methods to overcome resistance: a review. Cell Biosci. 2020; 10:35. PMID: 32180937.
-
Patel M, Li C, Aronson JH, Howie CM, Maraboyina S, Prabhu AV, Kim T. The effect of post mastectomy radiation therapy on survival in breast cancer patients with N1mic disease. Breast. 2020 Jun; 51:50-56. PMID: 32213441.
-
Patel M, Im J, Ivy A, Maraboyina S, Kim T. The epidemiology and role of surgery in the treatment of urethral clear cell carcinoma. Int Urol Nephrol. 2020 Jan; 52(1):51-57. PMID: 31555949.
-
Atiq SO, Atiq OO, Atiq MO, Phillips KC, Jacks BB, Moreno M, Maraboyina S, Atiq OT. The Role of Immunotherapy and Radiation Therapy in Tumor Chemosensitivity in Advanced Head and Neck Cancer. Am J Case Rep. 2018 Oct 18; 19:1241-1244. PMID: 30333474.
-
Narayanasamy G, Desai D, Maraboyina S, Penagaricano J, Zwicker R, Johnson EL. A Dose Falloff Gradient Study in RapidArc Planning of Lung Stereotactic Body Radiation Therapy. J Med Phys. 2018 Jul-Sep; 43(3):147-154. PMID: 30305771.
-
Narayanasamy G, Desai D, Morrill S, Zhang X, Galhardo E, Maraboyina S, Penagaricano J. Technical Note: A planning technique to lower normal tissue toxicity in lung SBRT plans based on two likely dependent RTOG metrics. Med Phys. 2018 May; 45(5):2325-2328. PMID: 29480933.
-
Zhang X, Rong Y, Morrill S, Fang J, Narayanasamy G, Galhardo E, Maraboyina S, Croft C, Xia F, Penagaricano J. Robust optimization in lung treatment plans accounting for geometric uncertainty. J Appl Clin Med Phys. 2018 May; 19(3):19-26. PMID: 29524301.
-
Narayanasamy G, Zhang X, Meigooni A, Paudel N, Morrill S, Maraboyina S, Peacock L, Penagaricano J. Therapeutic benefits in grid irradiation on Tomotherapy for bulky, radiation-resistant tumors. Acta Oncol. 2017 Aug; 56(8):1043-1047. PMID: 28270018.
-
Ram TS, Badkul R, Maraboyina S, Wang F. A comparative study to evaluate the efficacy of on board imaging with cone beam CT using target registration in patients with lung tumors undergoing stereotactic body radiation therapy and comparison with ExacTrac using skeletal registration on Novalis Tx. J Cancer Res Ther. 2011 Jul-Sep; 7(3):304-7. PMID: 22044812.
This graph shows the total number of publications by year, by first, middle/unknown, or last author.
To see the data from this visualization as text, click here.
| Year | Publications |
|---|
| 2011 | 1 | | 2017 | 1 | | 2018 | 4 | | 2019 | 1 | | 2020 | 4 | | 2022 | 1 | | 2023 | 4 | | 2024 | 1 |
To return to the timeline, click here.
|
Maraboyina's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|